Makedonia Palace Hotel, Thessaloniki
31/10 – 3/11/2019
From 31/10 to 3/11/2019, the 15th Panhellenic Conference for Dermatology and Venereology took place in hotel Makedonia Palace, Thessaloniki. IASIS PHARMA had an active participation, proving once more its strong interest in the fields of Dermatology and Venereology.
Dermatologists who attended the conference visited IASIS PHARMA stand, having the opportunity to be informed about two of its major dermatological products· Modiwart® and Ιsotroin®.
Modiwart®, with imiquimod as its active ingredient, is an innovative immunomodulator, with the following indications:
• external genital and anogenital warts (condyloma acuminata) in adults.
• small superficial basal cell carcinomas (sBCCs).
• clinically typical actinic keratosis.
Modiwart® is available as a cream (5%) for topical use, in single-use sachets (12 per package).
IASIS PHARMA also exhibited one of its most well-established product: Ιsotroin® (active ingredient: isotretinoin). It is a retinoid for the treatment of acne, available in soft caps of 10mg, 20mg and 40mg strength, helping the dermatologist to better customize the patient dosage scheme.
There was also strong interest for Combi®, a miconazole + fluprednidene combination in the form of cream, having excellent texture and the advantage of 50g per pack.
